Validation of Rehab Assessments in Myositis Patients

February 20, 2017 updated by: University of Zurich

Validation of Manual Muscle Testing and the Myositis Activity Profile Assessments in Patients With Inflammatory Myositis

The aim of the study is to evaluate the psychometric properties (content and construct validity, reliability, measurements error, as well as possible floor and ceiling effects) of both the assessments MMT8 and the myositis activity profile in patients with IM.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study evaluates the validity and reliability of two health related instruments that assess disease relevant functions and disabilities in patients with IM: the manual muscle testing 8 (MMT8) and the myositis activity profile (MAP). This study is needed to determine the psychometric properties of these two assessments. Provided that both the MMT8 and the MAP show good psychometric properties, these assessments could be used in the rehabilitation process and intervention programs of patients with IM to determine progress in muscle strength and activity in daily life.

Methodology: Reliability (Test re-test study and validity (cross sectional study) of a short form of MMT 8 and a questionnaire to assess difficulties in activities of daily life (MAP) in myositis patients.

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zurich, Switzerland, 8091
        • University Hospital Zurich

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

  1. Patients with diagnosed inflammatory myopathy
  2. Age and gender matched controls

Description

Inclusion Criteria:

  • Diagnosis of polymyositis or dermatomyositis or inflammatory myositis associated disorders (e.g. Scleroderma, Systematic lupus erythematosus, Sjögren's syndrome)
  • Age over 18
  • Sufficiently understanding of German language
  • able to understand and follow verbal and written instructions
  • signed informed consent to participate in the study

Exclusion Criteria:

  • Diagnosis of inclusion body myositis
  • Pulmonary hypertension
  • Osteoporosis
  • Severe cardiovascular and/or pulmonary disease
  • Pain syndrome
  • Paresis

Inclusion Criteria aged and gender matched healthy controls (Systematic lupus erythematosus, Sjögren's syndrome)

  • Age over 18
  • Sufficiently understanding of German language
  • able to understand and follow verbal and written instructions
  • signed informed consent to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Manual Muscle Testing 8 (MMT8)
Time Frame: 15 minutes
The strength of 8 Muscle groups is tested in a defined position and rewarded with a score varying from 0 (No visible movement) to 10 (holds test position against strong pressure) and summed for a potential score from 0-80.
15 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quantitative Muscle Testing
Time Frame: 15 Minutes
Hand Held Dynamometer in Newton
15 Minutes
Functional Index 2
Time Frame: 30 minutes
Evaluates muscle endurance of the upper & lower extremity and neck flexors movements: amount of repetitions.
30 minutes
Functional Test Battery (FTB): Test 1 Self-Performed Physical Performance Test.
Time Frame: Total FTB: 1 1/4 hours
Time in seconds to get up and sit down 5 times from a chair.
Total FTB: 1 1/4 hours
Functional Test Battery (FTB): Balance Test
Time Frame: Total FTB: 1 1/4 hours
Time in seconds (max 10 sec.) 1) balance feet together, 2) semi-tandem, 3) full-tandem stand.
Total FTB: 1 1/4 hours
Functional Test Battery ( FTB): Walk test ( 4 m)
Time Frame: Total FTB: 1 1/4 hours
Time in sec.
Total FTB: 1 1/4 hours
Functional Test Battery ( FTB): 1 leg stand
Time Frame: Total FTB: 1 1/4 hours
Time in sec.
Total FTB: 1 1/4 hours
Functional Test Battery ( FTB): Grip ability Test
Time Frame: Total FTB: 1 1/4 hours
Time in sec. (max 60 sec.)
Total FTB: 1 1/4 hours
Functional Test Battery ( FTB): Jamar grip test
Time Frame: Total FTB: 1 1/4 hours
Strength in Kg.
Total FTB: 1 1/4 hours
Functional Test Battery ( FTB): Pile Test
Time Frame: Total FTB: 1 1/4 hours
Work = Joule & Performance = Watt
Total FTB: 1 1/4 hours
Functional Test Battery ( FTB): 6 Minute walk-test
Time Frame: Total FTB: 1 1/4 hours
Meters during 6 minutes
Total FTB: 1 1/4 hours
Modified Myositis Activity Profile
Time Frame: 30 Minutes
34 item Questionnaire
30 Minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Baschung Pfister Pierrette, MPH, University of Zurich

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 1, 2014

Primary Completion (ACTUAL)

August 1, 2015

Study Completion (ACTUAL)

May 1, 2016

Study Registration Dates

First Submitted

February 9, 2017

First Submitted That Met QC Criteria

February 20, 2017

First Posted (ACTUAL)

February 23, 2017

Study Record Updates

Last Update Posted (ACTUAL)

February 23, 2017

Last Update Submitted That Met QC Criteria

February 20, 2017

Last Verified

February 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

The dataset analyzed in the current study is available from the corresponding author(s) on reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myositis

Clinical Trials on Non intervention study

Subscribe